About us
Publisher:
MEDVERSE LLC
Editor-in-Chief:
Grażyna BURZYŃSKA
e-mail: grazyna.burzynska@onet.pl
Scientific Council:
dr Edyta ADAMCZYK-KUTERA
dr Bernard DEBERRY BOROWIECKI
prof. dr hab. n. med. Halina CAR (medycyna i farmakologia)
dr n. med. Robert KOWALCZYK (psychologia i seksuologia kliniczna; biegły sądowy)
dr n. med. Lubomir LEMBAS (chirurgia plastyczna)
dr hab. n. med. Natalia LEWKOWICZ (stomatologia, periodontologia)
prof. dr hab. n. med. Waldemar PLACEK (dermatologia)
prof. dr hab. n. med. Marek POSTUŁA (kardiologia)
prof. dr hab. n. med. Adam REICH (dermatologia)
prof. dr hab. n. med. Violetta SKRZYPULEC-PLINTA (ginekologia, seksuologia)
prof. dr hab. n. med. Ewa STACHOWSKA (żywienia człowieka, metabolomika)
dr n. med. Piotr WIERZBIŃSKI (psychiatria)
Review procedure and ethical standards
1. All papers are accepted for publication after being reviewed favorably in accordance with the double-blind review principle. The review is based on a question sheet; the reviewer may also add comments. The reviewer shall notify the Editorial Board of any conflicts of interest between the reviewer and the organization funding the research presented in the paper.
2. The Editorial Board is responsible for decisions concerning the publishing of all contents featured in the journal; it operates impartially and is guided solely by the scientific merits of a paper (and also by the principles of humanitarian and ethics).
3. Any experimental research discussed in published original papers, which were conducted with the participation of patients and/or volunteers, or on animals, must be approved by an ethics committee. The principles of the Helsinki Declaration – Ethical Principles for Medical Research Involving Human Subjects of the World Medical Association (as of 2013) shall apply to all medical research involving human subjects; the Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes, the Act of 15 January 2015 on the protection of animals used for scientific or educational purposes (Polish Journal of Laws of 26 February 2015, item 266) with the relevant regulations, as well as the current resolutions/requirements of the National Ethical Committee on Animal Experimentation shall apply to research on animals.
The consent of an ethics committee is also required for research involving human biological material and documentation featuring patient identification data. Authors should include this information in the section „Material and methods”.
4. Conflict of interest: authors should provide information about the funding of research and the possible funder’s impact on the contents of a paper, as well as disclose facts about the author’s affiliation, consulting, paid expertise, etc. that may give rise to a conflict of interest.
5. The Editorial Board is of the opinion that adding a person as a co-author if they have not contributed significantly to the work or whose contribution was minimal (the so-called guest authorship), or failing to mention as a co-author or individually recognizing in the acknowledgements a person who made substantial contributions to the research are manifestations of scientific misconduct, and such cases shall be exposed.
1. All papers are accepted for publication after being reviewed favorably in accordance with the double-blind review principle. The review is based on a question sheet; the reviewer may also add comments. The reviewer shall notify the Editorial Board of any conflicts of interest between the reviewer and the organization funding the research presented in the paper.
2. The Editorial Board is responsible for decisions concerning the publishing of all contents featured in the journal; it operates impartially and is guided solely by the scientific merits of a paper (and also by the principles of humanitarian and ethics).
3. Any experimental research discussed in published original papers, which were conducted with the participation of patients and/or volunteers, or on animals, must be approved by an ethics committee. The principles of the Helsinki Declaration – Ethical Principles for Medical Research Involving Human Subjects of the World Medical Association (as of 2013) shall apply to all medical research involving human subjects; the Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes, the Act of 15 January 2015 on the protection of animals used for scientific or educational purposes (Polish Journal of Laws of 26 February 2015, item 266) with the relevant regulations, as well as the current resolutions/requirements of the National Ethical Committee on Animal Experimentation shall apply to research on animals.
The consent of an ethics committee is also required for research involving human biological material and documentation featuring patient identification data. Authors should include this information in the section „Material and methods”.
4. Conflict of interest: authors should provide information about the funding of research and the possible funder’s impact on the contents of a paper, as well as disclose facts about the author’s affiliation, consulting, paid expertise, etc. that may give rise to a conflict of interest.
5. The Editorial Board is of the opinion that adding a person as a co-author if they have not contributed significantly to the work or whose contribution was minimal (the so-called guest authorship), or failing to mention as a co-author or individually recognizing in the acknowledgements a person who made substantial contributions to the research are manifestations of scientific misconduct, and such cases shall be exposed.
Rules of publishing
1. Only a text that has not been previously published or submitted for publication may be accepted for publication. If the text has more than one author, the consent of each co-author for its publication should be submitted.
2. Provide the name, surname and academic title of the author(s) of a paper, the clinic or institution where the paper was created, along with the name, surname and academic title of the manager, as well as the correspondence address.
3. A paper should be accompanied by keywords and an abstract of 150-250 words in Polish and English, along with the English title of the paper. In original papers, the abstract should consist of the following sections: „Introduction”, “Materials and Methods”, „Results”, “Discussion”, and „Conclusions”.
4. Research papers should contain the following subsections: „Introduction”, “Materials and Methods”, „Results”, „Discussion”, and „Conclusions”.
5. International names of drugs should be used in the nominative case written with a capital letter, in other cases – Polonized names written with a lower case letter.
6. References cited should be included at the end of the paper, numbered and arranged in the order they are cited. Sequential numbers are used in the text to refer to the bibliographic references at the end of the paper, in parentheses, e.g. [9] or [1,3,6,9].
7. Each bibliographic reference ought to contain surnames along with the first letters of the first names of the first six authors (if there are more authors, use the abbreviation „et al.”), the full title of the paper, the name of the journal according to Index Medicus, year, volume, and pages. The publisher, the place and year of publication, and page should be provided for books or independent papers after the surnames and first names of the authors and the title. The title of the chapter, editors, and title of the publication, publisher, place and year of publication, volume and page should be specified for multi-author publications.
8. Review papers should contain 10-40 references.
9. For research projects funded by specific companies or institutions, the relevant information should be included at the end of the paper.
10. The text must be delivered by e-mail (as a text document). Photographs and graphs should be submitted in separate files (TIFF format: 300 DPI, 1:1, uncompressed; or JPG format: 300 DPI, maximum quality, uncompressed), numbered, with captions in Polish and English.
11. For photos, attach the consent of the persons depicted (or information about the lack of such consent) and the consent of the author of the photos for publication.
12. When using any contents from other sources, authors should obtain the consent of the copyright owner and specify the origin of such contents.
13. The submitted paper shall be subject to double-anonymous peer review.
14. The Editorial Board reserves the right to introduce changes in terms of the style and logic, as well as abbreviations in the papers without first consulting the author.
15. By submitting a paper for publication, the author transfers economic copyrights in this paper to the publisher of “Medycyna Funkcjonalna i Estetyka Lekarska” journal, and specifically the right to record, reproduce in print or by any other technique of your choice, place on the market (including in electronic media) and authorize further reprints.
16. By submitting a paper for publication, the author confirms that they have read and accepted the terms of these regulations.
1. Only a text that has not been previously published or submitted for publication may be accepted for publication. If the text has more than one author, the consent of each co-author for its publication should be submitted.
2. Provide the name, surname and academic title of the author(s) of a paper, the clinic or institution where the paper was created, along with the name, surname and academic title of the manager, as well as the correspondence address.
3. A paper should be accompanied by keywords and an abstract of 150-250 words in Polish and English, along with the English title of the paper. In original papers, the abstract should consist of the following sections: „Introduction”, “Materials and Methods”, „Results”, “Discussion”, and „Conclusions”.
4. Research papers should contain the following subsections: „Introduction”, “Materials and Methods”, „Results”, „Discussion”, and „Conclusions”.
5. International names of drugs should be used in the nominative case written with a capital letter, in other cases – Polonized names written with a lower case letter.
6. References cited should be included at the end of the paper, numbered and arranged in the order they are cited. Sequential numbers are used in the text to refer to the bibliographic references at the end of the paper, in parentheses, e.g. [9] or [1,3,6,9].
7. Each bibliographic reference ought to contain surnames along with the first letters of the first names of the first six authors (if there are more authors, use the abbreviation „et al.”), the full title of the paper, the name of the journal according to Index Medicus, year, volume, and pages. The publisher, the place and year of publication, and page should be provided for books or independent papers after the surnames and first names of the authors and the title. The title of the chapter, editors, and title of the publication, publisher, place and year of publication, volume and page should be specified for multi-author publications.
8. Review papers should contain 10-40 references.
9. For research projects funded by specific companies or institutions, the relevant information should be included at the end of the paper.
10. The text must be delivered by e-mail (as a text document). Photographs and graphs should be submitted in separate files (TIFF format: 300 DPI, 1:1, uncompressed; or JPG format: 300 DPI, maximum quality, uncompressed), numbered, with captions in Polish and English.
11. For photos, attach the consent of the persons depicted (or information about the lack of such consent) and the consent of the author of the photos for publication.
12. When using any contents from other sources, authors should obtain the consent of the copyright owner and specify the origin of such contents.
13. The submitted paper shall be subject to double-anonymous peer review.
14. The Editorial Board reserves the right to introduce changes in terms of the style and logic, as well as abbreviations in the papers without first consulting the author.
15. By submitting a paper for publication, the author transfers economic copyrights in this paper to the publisher of “Medycyna Funkcjonalna i Estetyka Lekarska” journal, and specifically the right to record, reproduce in print or by any other technique of your choice, place on the market (including in electronic media) and authorize further reprints.
16. By submitting a paper for publication, the author confirms that they have read and accepted the terms of these regulations.
MEDVERSE LLC
- Pustułeczki 30/U5
- 02-811 Warsaw
- NIP: 9512532986
- REGON: 52097955300000
- KRS: 0000945427
- contact@offlabel.co
shortcuts
Newsletter
By subscribing to the newsletter, you will receive up-to-date information on events, conferences and the latest knowledge.
FM&MA
MEDVERSE LLC
- Pustułeczki 30/U5
- 02-811 Warsaw
- NIP: 9512532986
- REGON: 52097955300000
- KRS: 0000945427
- contact@offlabel.co
shortcuts
Newsletter
By subscribing to the newsletter, you will receive up-to-date information on events, conferences and the latest knowledge.